CEOs from AstraZeneca, GSK, Merck KGaA, Novo Nordisk, Roche, Samsung Biologics and Sanofi announced joint action to achieve near-term emissions reduction targets and accelerate the delivery of net zero health systems.
Key highlights:
- CEOs from large pharma brands have united under a Task Force to achieve near-term emissions reduction targets and accelerate the delivery of net zero health systems.
- Member companies of the Task Force have identified 3 key areas to target decarbonisation: supply chains, patient care pathways, and clinical trials.
- The Task Force is partnering with the WHO-convened Alliance for Transformative Action on Health and Climate (ATACH) to provide recommendations to over 60 governments.
For the first time, the global health sector has come together to reduce greenhouse gas emissions through the Sustainable Markets Initiative (SMI) Health Systems Task Force, a public-private partnership launched at COP26.